A new approach for selecting patients with metastatic breast cancer for hypophysectomy.
D000367:Age Factors; D000728:Androgens / Q000627:therapeutic use; D000818:Animals; D001551:Benz(a)Anthracenes; D001665:Binding Sites; D001940:Breast / Q000187:drug effects; D001943:Breast Neoplasms / Q000175:diagnosis / Q000378:metabolism / Q000628:therapy*; D002369:Castration; D002467:Cell Nucleus / Q000378:metabolism; D002499:Centrifugation, Density Gradient; D003593:Cytoplasm / Q000378:metabolism; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D006589:Hexestrol / Q000378:metabolism; D006801:Humans; D007016:Hypophysectomy; D007116:Immunization, Passive; D007774:Lactation; D007980:Levodopa / Q000627:therapeutic use; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced; D009362:Neoplasm Metastasis; D009924:Organ Culture Techniques; D011247:Pregnancy; D011388:Prolactin / Q000494:pharmacology; D051381:Rats; D011956:Receptors, Cell Surface; D013395:Sucrose; D014316:Tritium
D000728:Androgens; D001551:Benz(a)Anthracenes; D004967:Estrogens; D011956:Receptors, Cell Surface; D014316:Tritium; D006589:Hexestrol; D007980:Levodopa; D013395:Sucrose; D011388:Prolactin